7. Malignant and Salivary Gland Neoplasms

Embed Size (px)

Citation preview

  • 7/29/2019 7. Malignant and Salivary Gland Neoplasms

    1/15

    MALIGNANT LESIONS

    Prepared by: Gustavo A. Reyes

  • 7/29/2019 7. Malignant and Salivary Gland Neoplasms

    2/15

    Bronchial Carcinoma- any epithelial carcinoma occuring

    in the bronchopulmonary tree.

    Neuroendocrine Tumors

    -Typical Carcinoid

    -Atypical Carcinoid

    -Large cell neuroendocrinecarcinoma.

    -Small Cell Carcinoma

    BRONCHIAL

    CARCINOMA

    Non- Small Cell Lung

    Carcinomas

    -Squamous Cell

    Carcinoma

    -Large Cell Carcinoma

    -Adenocarcinoma

    - Bronchoalveolar

    carcinoma

  • 7/29/2019 7. Malignant and Salivary Gland Neoplasms

    3/15

    Currently, the pathologic diagnosis of lung

    cancer is based on light microscopic criteria.

    Immuno-histochemical staining & electron

    microscopy are used as adjuncts in diagnosis,

    particularly in the assessment of

    neuroendocrine tumors.

  • 7/29/2019 7. Malignant and Salivary Gland Neoplasms

    4/15

    Non- Small Cell Lung Carcinoma

    Encompasses many tumor cell types, including

    adenocarcinoma, squamous cell carcinoma &

    large cell carcinoma.

    Although they differ in appearance

    histologically, their clinical behavior &

    treatment options are similar.

  • 7/29/2019 7. Malignant and Salivary Gland Neoplasms

    5/15

    Squamous Cell Carcinoma

    30-40% of lung cancers. Males> Females; highly associated with

    cigarrete smoking.

    Histologically: cells develop a pattern ofclusters with intracellular bridges & keratin

    pearls.

  • 7/29/2019 7. Malignant and Salivary Gland Neoplasms

    6/15

    Primarily located centrally & arises in the major

    bronchi.

    - Hemoptysis

    - bronchial obstruction- Atelectasis

    * Central Necrosis is frequent with resultantabscess formation.

  • 7/29/2019 7. Malignant and Salivary Gland Neoplasms

    7/15

    Adenocarcinoma

    25-40% of all lung cancers.

    Females> Males.

    Peripherally based tumor.

    Histologically: composed of glands with or without

    mucin production, combined with destruction ofcontiguous lung architecture.

  • 7/29/2019 7. Malignant and Salivary Gland Neoplasms

    8/15

    Bronchoalveolar Carcinoma

    5% of all lung cancers.

    Its a subtype of adenocarcinoma.

    Differs from adenocarcinoma in that, rather than

    invading & destroying lung parenchyma, its tumor

    cells multiply and fill the alveolar spaces.

    It grows within alveoli/alveolar spaces: tumor cellscan seed aerogenously to other parts of the same

    lobe, lung or contralateral lung.

  • 7/29/2019 7. Malignant and Salivary Gland Neoplasms

    9/15

    Bronchoalveolar carcinoma

    Columnar Cells that proliferate along the framework of

    alveolar septae.

  • 7/29/2019 7. Malignant and Salivary Gland Neoplasms

    10/15

    Large Cell Carcinoma

    10-20% of lung cancers. Maybe located centrally or peripherally.

    30-50 m. They are often admixed with other

    cell types such as squamous cells oradenocarcinoma.

  • 7/29/2019 7. Malignant and Salivary Gland Neoplasms

    11/15

    Neuroendocrine Neoplasms

    Essential Neuroendocrine Markers for Dx:

    -Chromogranins

    -Synapthophysin

    - CD57

    -Neuron-specific Enolase

    Grade I NEC(neuroendocrine carcinoma)

    Grade II NEC

    Grade III

    Classical or Typical Carcinoid

    Atypical Carcinoid

    Large Cell Type/Small Cell type

  • 7/29/2019 7. Malignant and Salivary Gland Neoplasms

    12/15

    GRADE I NEC

    Classical/Typical

    Low grade epithelial tumor.

    Arises primarily in centralairways but can occur

    peripherally.

    Tumor cells are arranged in the

    cords and clusters with a rich

    vascular stroma.

    Regional lymph node

    metastases are seen in 15% ofpatients but rarely spread

    systematically of cause death.

    - Classicaly presents with;-

    Hemoptysis

    Airway obstruction

    Pneumonia

  • 7/29/2019 7. Malignant and Salivary Gland Neoplasms

    13/15

    GRADE II NEC

    Histologic findings may

    include necrosis, nuclear

    polymorphism & highermitotic rates.

    Lymph node metastases

    are found 30-50% of thepatients

    - Aggressive clinical behavior.

    - Etiologically linked to

    cigarrete smoking

    - Peripherally located

  • 7/29/2019 7. Malignant and Salivary Gland Neoplasms

    14/15

    GRADE III NEC

    Tumor consists of smaller

    cells (10-20um) that have

    very little cytoplasm & verydark nuclei.

    Tumors have mitotic rate &

    areas of extensive necrosis. Multiple mitoses are easily

    seen.

    -Most malignant.

    -Small Cell Lung Carcinoma.

    - 25% of all lung cancers.

    - Leading producers ofparaneoplastic syndromes.

    -Tumors are centrally located.

  • 7/29/2019 7. Malignant and Salivary Gland Neoplasms

    15/15

    Salivary gland-type neoplasm

    Histologically identical to those seen in the

    salivary glands.

    The 2 most common are adenoid cystic

    carcinoma & mucoepidermoid carcinoma.

    Both occurs centrally. Its a slow-growing

    tumor that is locally and sytemically invasive..

    It tends to grow submucosally and infiltrate

    along perineural sheaths.